“泉心药服”助力新药上市，济南医药创新再结硕果

Group 1 - The innovative drug Regaglitin Metformin Tablets developed by Shandong Shengdi Pharmaceutical Co., Ltd. has been officially approved for market launch, marking the ninth class 1 innovative drug approved in Shandong Province since the 14th Five-Year Plan [1] - Jinan has approved a total of 25 new drug products this year, ranking first in the province [1] - The Jinan Pharmaceutical Innovation Service Center has established a "one enterprise, one policy, full tracking" service system to address the long R&D cycles and high technical requirements of pharmaceutical innovation [1] Group 2 - The center provides pre-registration guidance, technical empowerment, and targeted financial support to assist enterprises in the drug development process [1] - The center aims to enhance its service philosophy of "full chain guidance + full element docking + full cycle tracking" to support high-quality development of the pharmaceutical industry [2] - The center is committed to achieving a 100% satisfaction rate for enterprise services through various mechanisms, including face-to-face service and zero-delay response to enterprise needs [2]